Company Information
USD
0.537
- (3.3%)
NASDAQ:IPSC, CENTURY THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Address
3675 Market Street
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Douglas Carr
CFO
Dr. Gregory Russotti, PhD
Chief Technology Officer/Other Executive Officer
Mr. Brent Pfeiffenberger
CEO/Director/President
Ms. Cynthia M. Butitta
Director
Dr. Hyam I. Levitsky,M.D.
President, Divisional
Mr. Joseph Jimenez
Chairman of the Board/Director
Mr. Timothy P. Walbert
Director
Ms. Daphne E. Quimi
Director
Dr. Kimberly Blackwell, M.D.
Director
Dr. Carlo Rizzuto, PhD
Director
Dr. Adrienne Farid, PhD
COO
Dr. Alessandro Riva, M.D.
Director
Ownership
Institution Holdings
Versant Venture Capital VI, LP
11,452,014 (19.139%)
FMR LLC
3,823,265 (6.390%)
FMR Inc
3,612,551 (6.038%)
Casdin Capital, LLC
3,206,380 (5.359%)
Fidelity Management & Research Company LLC
1,698,908 (2.839%)
Fidelity Management Trust Company
1,634,820 (2.732%)
BlackRock Inc
1,518,996 (2.539%)
Avidity Partners Management LP
1,355,000 (2.265%)
Dafna Capital Management LLC
1,307,407 (2.185%)
Vanguard Group Inc
1,124,653 (1.880%)
Individual Holdings
Mr. Brent Pfeiffenberger
1,453,279 (2.429%)
Mr. Joseph Jimenez
494,346 (0.902%)
Dr. Gregory Russotti, PhD
278,319 (0.508%)
Mr. Douglas Carr
303,580 (0.507%)
Dr. Adrienne Farid, PhD
114,149 (0.191%)
Ms. Cynthia M. Butitta
98,936 (0.181%)
Funds Holdings
Fidelity Growth Company Commingled Pool
1,634,820 (2.732%)
Fidelity Growth Company Fund
1,067,301 (1.784%)
Vanguard Total Stock Market Index Fund
628,424 (1.050%)
iShares Russell 2000 ETF
563,674 (0.942%)
Fidelity Growth Company K6 Fund
557,033 (0.931%)
iShares Russell 2000 Value ETF
227,982 (0.381%)
Fidelity Small Cap Index Fund
217,910 (0.364%)
Fidelity Series Growth Company Fund
170,408 (0.285%)
Fidelity Extended Market Index Fund
123,868 (0.207%)
Vanguard Russell 2000 Index Fund
77,589 (0.130%)
Make Smart Investment Choices